UniProt ID | A1AG2_HUMAN | |
---|---|---|
UniProt AC | P19652 | |
Protein Name | Alpha-1-acid glycoprotein 2 | |
Gene Name | ORM2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 201 | |
Subcellular Localization | Secreted. | |
Protein Description | Functions as transport protein in the blood stream. Binds various hydrophobic ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability. Appears to function in modulating the activity of the immune system during the acute-phase reaction.. | |
Protein Sequence | MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDRITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQNQCFYNSSYLNVQRENGTVSRYEGGREHVAHLLFLRDTKTLMFGSYLDDEKNWGLSFYADKPETTKEQLGEFYEALDCLCIPRSDVMYTDWKKDKCEPLEKQHEKERKQEEGES | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MALSWVLTVLS ----CHHHHHHHHHH | 12.95 | 24043423 | |
8 | Phosphorylation | MALSWVLTVLSLLPL CHHHHHHHHHHHHHH | 15.13 | 24043423 | |
11 | Phosphorylation | SWVLTVLSLLPLLEA HHHHHHHHHHHHHHC | 24.43 | 24043423 | |
19 | Pyrrolidone_carboxylic_acid | LLPLLEAQIPLCANL HHHHHHCCCCCCCCC | 28.58 | 15253437 | |
19 | Pyrrolidone_carboxylic_acid | LLPLLEAQIPLCANL HHHHHHCCCCCCCCC | 28.58 | 15253437 | |
19 | Pyrrolidone_carboxylic_acid | LLPLLEAQIPLCANL HHHHHHCCCCCCCCC | 28.58 | - | |
32 | Phosphorylation | NLVPVPITNATLDRI CCCEEECCCCCHHHH | 16.84 | 24043423 | |
33 | N-linked_Glycosylation | LVPVPITNATLDRIT CCEEECCCCCHHHHC | 31.48 | 22171320 | |
33 | N-linked_Glycosylation | LVPVPITNATLDRIT CCEEECCCCCHHHHC | 31.48 | 22171320 | |
35 | Phosphorylation | PVPITNATLDRITGK EEECCCCCHHHHCCC | 31.12 | 24043423 | |
40 | Phosphorylation | NATLDRITGKWFYIA CCCHHHHCCCEEEHH | 33.33 | 24043423 | |
45 | Nitration | RITGKWFYIASAFRN HHCCCEEEHHHHHCC | 8.41 | - | |
55 | Nitration | SAFRNEEYNKSVQEI HHHCCHHHHHHHHHC | 23.01 | - | |
56 | N-linked_Glycosylation | AFRNEEYNKSVQEIQ HHCCHHHHHHHHHCC | 33.15 | 1567356 | |
56 | N-linked_Glycosylation | AFRNEEYNKSVQEIQ HHCCHHHHHHHHHCC | 33.15 | 4711474 | |
65 | Phosphorylation | SVQEIQATFFYFTPN HHHHCCEEEEEECCC | 9.63 | 25627689 | |
68 | Nitration | EIQATFFYFTPNKTE HCCEEEEEECCCCCC | 11.44 | - | |
72 | N-linked_Glycosylation | TFFYFTPNKTEDTIF EEEEECCCCCCCEEE | 61.90 | 1567356 | |
72 | N-linked_Glycosylation | TFFYFTPNKTEDTIF EEEEECCCCCCCEEE | 61.90 | 18638581 | |
93 | N-linked_Glycosylation | RQNQCFYNSSYLNVQ CCCCCCCCCCCEEEE | 12.29 | 18638581 | |
93 | N-linked_Glycosylation | RQNQCFYNSSYLNVQ CCCCCCCCCCCEEEE | 12.29 | 1567356 | |
96 | Nitration | QCFYNSSYLNVQREN CCCCCCCCEEEEEEC | 11.34 | - | |
98 | N-linked_Glycosylation | FYNSSYLNVQRENGT CCCCCCEEEEEECCC | 21.46 | 17623646 | |
98 | N-linked_Glycosylation | FYNSSYLNVQRENGT CCCCCCEEEEEECCC | 21.46 | 17623646 | |
103 | N-linked_Glycosylation | YLNVQRENGTVSRYE CEEEEEECCCEEEEC | 54.33 | 4711474 | |
103 | N-linked_Glycosylation | YLNVQRENGTVSRYE CEEEEEECCCEEEEC | 54.33 | 1567356 | |
109 | Nitration | ENGTVSRYEGGREHV ECCCEEEECCCHHEE | 16.06 | - | |
132 | Phosphorylation | TKTLMFGSYLDDEKN CCEEEECCEECCCCC | 15.97 | 24043423 | |
133 | Nitration | KTLMFGSYLDDEKNW CEEEECCEECCCCCC | 17.96 | - | |
133 | Phosphorylation | KTLMFGSYLDDEKNW CEEEECCEECCCCCC | 17.96 | 24043423 | |
145 | Nitration | KNWGLSFYADKPETT CCCCCEEECCCCCCC | 15.54 | - | |
160 | Nitration | KEQLGEFYEALDCLC HHHHHHHHHHHHHEE | 8.94 | - | |
175 | Nitration | IPRSDVMYTDWKKDK EEHHHCCCCCCCCCC | 11.03 | - | |
179 | Acetylation | DVMYTDWKKDKCEPL HCCCCCCCCCCCHHH | 54.63 | 30586329 | |
188 | Glycation | DKCEPLEKQHEKERK CCCHHHHHHHHHHHH | 65.72 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of A1AG2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of A1AG2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of A1AG2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
STK3_HUMAN | STK3 | physical | 21988832 | |
PRDX6_HUMAN | PRDX6 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD."; Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.; Mol. Cell. Proteomics 0:0-0(2011). Cited for: GLYCOSYLATION AT ASN-33, STRUCTURE OF CARBOHYDRATES, AND MASSSPECTROMETRY. | |
"Enrichment of glycopeptides for glycan structure and attachment siteidentification."; Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,Brinkmalm G., Larson G.; Nat. Methods 6:809-811(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33, STRUCTURE OFCARBOHYDRATES, AND MASS SPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-93 ANDASN-103, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93AND ASN-103, AND MASS SPECTROMETRY. | |
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72 ANDASN-93, AND MASS SPECTROMETRY. | |
"A proteomic analysis of human bile."; Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.; Mol. Cell. Proteomics 3:715-728(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33, AND MASS SPECTROMETRY. | |
"A new strategy for identification of N-glycosylated proteins andunambiguous assignment of their glycosylation sites using HILICenrichment and partial deglycosylation."; Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., Roepstorff P.; J. Proteome Res. 3:556-566(2004). Cited for: PYROGLUTAMATE FORMATION AT GLN-19, GLYCOSYLATION AT ASN-33 AND ASN-93,AND MASS SPECTROMETRY. | |
"Analysis of the five glycosylation sites of human alpha 1-acidglycoprotein."; Treuheit M.J., Costello C.E., Halsall H.B.; Biochem. J. 283:105-112(1992). Cited for: GLYCOSYLATION AT ASN-33; ASN-56; ASN-72; ASN-93 AND ASN-103. |